Cargando…

Dementia-related neuropsychiatric symptoms: inequalities in pharmacological treatment and institutionalization

BACKGROUND: Dementia-related neuropsychiatric symptoms (NPS) are the main determinant of family stress and institutionalization of patients. This study aimed to identify inequalities by gender and socioeconomic status in the management of NPS in patients diagnosed with dementia. METHODS: An observat...

Descripción completa

Detalles Bibliográficos
Autores principales: Mar, Javier, Arrospide, Arantzazu, Soto-Gordoa, Myriam, Iruin, Álvaro, Tainta, Mikel, Gabilondo, Andrea, Mar-Barrutia, Lore, Calvo, Montserrat, Mateos, Maider, Ibarrondo, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657654/
https://www.ncbi.nlm.nih.gov/pubmed/31413574
http://dx.doi.org/10.2147/NDT.S209008
_version_ 1783438828628869120
author Mar, Javier
Arrospide, Arantzazu
Soto-Gordoa, Myriam
Iruin, Álvaro
Tainta, Mikel
Gabilondo, Andrea
Mar-Barrutia, Lore
Calvo, Montserrat
Mateos, Maider
Ibarrondo, Oliver
author_facet Mar, Javier
Arrospide, Arantzazu
Soto-Gordoa, Myriam
Iruin, Álvaro
Tainta, Mikel
Gabilondo, Andrea
Mar-Barrutia, Lore
Calvo, Montserrat
Mateos, Maider
Ibarrondo, Oliver
author_sort Mar, Javier
collection PubMed
description BACKGROUND: Dementia-related neuropsychiatric symptoms (NPS) are the main determinant of family stress and institutionalization of patients. This study aimed to identify inequalities by gender and socioeconomic status in the management of NPS in patients diagnosed with dementia. METHODS: An observational study was carried out to study all the cases of dementia in the corporate database of the Basque Health Service (29,864 patients). The prescription of antipsychotics and antidepressants and admission to a nursing home were used to establish the presence of NPS. The socioeconomic status of individuals was classified by a deprivation index. Logistic regressions were used to identify drivers for drug prescriptions and institutionalization. RESULTS: NPS are poorly recorded in the clinical databases (12%). Neuropsychiatric symptoms were severe enough in two thirds of patients with dementia to be treated with psychoactive medication. Institutionalization showed an increase from those who did not receive medication to those who had been prescribed antidepressants (OR: 1.546), antipsychotics (OR: 2.075) or both (OR: 2.741). The resulting inequalities were the increased prescription of antidepressant drugs in women and more nursing-home admissions for women who were the least socioeconomically deprived and men who were the most deprived. CONCLUSIONS: In large clinical databases, psychoactive drugs prescriptions can be useful to underscore the considerable burden of dementia-related NPS. Specific tools are needed to monitor social and health care programs targeted to dementia-related NPS from a population perspective. Programs aimed at reducing the family burden of care of dementia patients at home become the key elements in reducing inequalities in these patients’ care. Socioeconomic status is the most important driver of inequality, and gender inequality may simply be hidden within the social environment. Integrated programs boosting the continuity of care are an objective for which compliance could be measured according to the NPS coding in the electronic health record.
format Online
Article
Text
id pubmed-6657654
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-66576542019-08-14 Dementia-related neuropsychiatric symptoms: inequalities in pharmacological treatment and institutionalization Mar, Javier Arrospide, Arantzazu Soto-Gordoa, Myriam Iruin, Álvaro Tainta, Mikel Gabilondo, Andrea Mar-Barrutia, Lore Calvo, Montserrat Mateos, Maider Ibarrondo, Oliver Neuropsychiatr Dis Treat Original Research BACKGROUND: Dementia-related neuropsychiatric symptoms (NPS) are the main determinant of family stress and institutionalization of patients. This study aimed to identify inequalities by gender and socioeconomic status in the management of NPS in patients diagnosed with dementia. METHODS: An observational study was carried out to study all the cases of dementia in the corporate database of the Basque Health Service (29,864 patients). The prescription of antipsychotics and antidepressants and admission to a nursing home were used to establish the presence of NPS. The socioeconomic status of individuals was classified by a deprivation index. Logistic regressions were used to identify drivers for drug prescriptions and institutionalization. RESULTS: NPS are poorly recorded in the clinical databases (12%). Neuropsychiatric symptoms were severe enough in two thirds of patients with dementia to be treated with psychoactive medication. Institutionalization showed an increase from those who did not receive medication to those who had been prescribed antidepressants (OR: 1.546), antipsychotics (OR: 2.075) or both (OR: 2.741). The resulting inequalities were the increased prescription of antidepressant drugs in women and more nursing-home admissions for women who were the least socioeconomically deprived and men who were the most deprived. CONCLUSIONS: In large clinical databases, psychoactive drugs prescriptions can be useful to underscore the considerable burden of dementia-related NPS. Specific tools are needed to monitor social and health care programs targeted to dementia-related NPS from a population perspective. Programs aimed at reducing the family burden of care of dementia patients at home become the key elements in reducing inequalities in these patients’ care. Socioeconomic status is the most important driver of inequality, and gender inequality may simply be hidden within the social environment. Integrated programs boosting the continuity of care are an objective for which compliance could be measured according to the NPS coding in the electronic health record. Dove 2019-07-17 /pmc/articles/PMC6657654/ /pubmed/31413574 http://dx.doi.org/10.2147/NDT.S209008 Text en © 2019 Mar et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Mar, Javier
Arrospide, Arantzazu
Soto-Gordoa, Myriam
Iruin, Álvaro
Tainta, Mikel
Gabilondo, Andrea
Mar-Barrutia, Lore
Calvo, Montserrat
Mateos, Maider
Ibarrondo, Oliver
Dementia-related neuropsychiatric symptoms: inequalities in pharmacological treatment and institutionalization
title Dementia-related neuropsychiatric symptoms: inequalities in pharmacological treatment and institutionalization
title_full Dementia-related neuropsychiatric symptoms: inequalities in pharmacological treatment and institutionalization
title_fullStr Dementia-related neuropsychiatric symptoms: inequalities in pharmacological treatment and institutionalization
title_full_unstemmed Dementia-related neuropsychiatric symptoms: inequalities in pharmacological treatment and institutionalization
title_short Dementia-related neuropsychiatric symptoms: inequalities in pharmacological treatment and institutionalization
title_sort dementia-related neuropsychiatric symptoms: inequalities in pharmacological treatment and institutionalization
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657654/
https://www.ncbi.nlm.nih.gov/pubmed/31413574
http://dx.doi.org/10.2147/NDT.S209008
work_keys_str_mv AT marjavier dementiarelatedneuropsychiatricsymptomsinequalitiesinpharmacologicaltreatmentandinstitutionalization
AT arrospidearantzazu dementiarelatedneuropsychiatricsymptomsinequalitiesinpharmacologicaltreatmentandinstitutionalization
AT sotogordoamyriam dementiarelatedneuropsychiatricsymptomsinequalitiesinpharmacologicaltreatmentandinstitutionalization
AT iruinalvaro dementiarelatedneuropsychiatricsymptomsinequalitiesinpharmacologicaltreatmentandinstitutionalization
AT taintamikel dementiarelatedneuropsychiatricsymptomsinequalitiesinpharmacologicaltreatmentandinstitutionalization
AT gabilondoandrea dementiarelatedneuropsychiatricsymptomsinequalitiesinpharmacologicaltreatmentandinstitutionalization
AT marbarrutialore dementiarelatedneuropsychiatricsymptomsinequalitiesinpharmacologicaltreatmentandinstitutionalization
AT calvomontserrat dementiarelatedneuropsychiatricsymptomsinequalitiesinpharmacologicaltreatmentandinstitutionalization
AT mateosmaider dementiarelatedneuropsychiatricsymptomsinequalitiesinpharmacologicaltreatmentandinstitutionalization
AT ibarrondooliver dementiarelatedneuropsychiatricsymptomsinequalitiesinpharmacologicaltreatmentandinstitutionalization